The approval of the ITA is an important step towards getting the Multiplo ® Complete Syphilis (TP/nTP) Antibody Test licensed and into the Canadian market. MedMira offers the only commercially ...

The approval of the ITA is an important step towards getting the Multiplo ® Complete Syphilis (TP/nTP) Antibody Test licensed and into the Canadian market. MedMira offers the only commercially ...

The approval of the ITA is an important step towards getting the Multiplo® Complete Syphilis (TP/nTP) Antibody Test licensed and into the Canadian market. MedMira offers the only commercially ...

Amid these soaring cases, particularly in underserved and remote communities in the Prairies, the Multiplo® TP/HIV rapid self-test and non-professional tests provides a 'missing key' to help reach the ...

from Health Canada to begin clinical trials for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP), a cutting edge device that can determine active and non-active syphilis.

As rates of syphilis and HIV continue to climb in Canada, a dual rapid test recently was approved by federal regulators,.

The approved Multiplo® TP/HIV rapid test is easy to use, providing immediate results from a single finger-prick blood sample. It detects both syphilis and HIV antibodies, and if positive ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Medmira ( (TSE ...